NS · Pharmaceuticals

Akums Drugs & Pharmaceuticals Ltd (AKUMS)

Pharmaceuticals & Biotechnology

Akums Drugs & Pharmaceuticals Ltd (AKUMS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $97.58B, P/E ratio is 87.45, dividend yield is 0.16%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AKUMS

Market cap

$97.58B

P/E ratio

87.45

Dividend yield

0.16%

Akums Drugs & Pharmaceuticals Ltd (AKUMS) — FAQ

What is Akums Drugs & Pharmaceuticals Ltd's market cap?

Akums Drugs & Pharmaceuticals Ltd (AKUMS) has a reported market cap of $97.58B (data as of 2026-07-11).

What is AKUMS's P/E ratio?

The price-to-earnings (P/E) ratio for Akums Drugs & Pharmaceuticals Ltd (AKUMS) is 87.45 (data as of 2026-07-11).

Does Akums Drugs & Pharmaceuticals Ltd pay a dividend?

Akums Drugs & Pharmaceuticals Ltd (AKUMS) shows a reported dividend yield of 0.16%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).

What sector is Akums Drugs & Pharmaceuticals Ltd in?

Akums Drugs & Pharmaceuticals Ltd (AKUMS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is AKUMS listed on?

AKUMS is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)